Author:
Boeddrich Annett,Babila Julius T.,Wiglenda Thomas,Diez Lisa,Jacob Manuela,Nietfeld Wilfried,Huska Matthew R.,Haenig Christian,Groenke Nicole,Buntru Alexander,Blanc Eric,Meier Jochen C.,Vannoni Elisabetta,Erck Christian,Friedrich Beate,Martens Henrik,Neuendorf Nancy,Schnoegl Sigrid,Wolfer David P.,Loos Maarten,Beule Dieter,Andrade-Navarro Miguel A.,Wanker Erich E.
Funder
German Federal Ministry for Education and Research
Berlin Institute of Health Collaborative Research
Helmholtz Validation Fund
Helmholtz Association, Germany
Max Delbrück Center
Deutsche Forschungsgemeinschaft
European Union
Subject
Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Biology,Molecular Medicine,Biochemistry
Reference58 articles.
1. Suppression by polycyclic compounds of the conversion of human amylin into insoluble amyloid;Aitken;Biochem. J.,2003
2. Chemical kinetics for drug discovery to combat protein aggregation diseases;Arosio;Trends Pharmacol. Sci.,2014
3. On the lag phase in amyloid fibril formation;Arosio;Phys. Chem. Chem. Phys.,2015
4. Optimization of intraperitoneal injection anesthesia in mice: drugs, dosages, adverse effects, and anesthesia depth;Arras;Comp. Med.,2001
5. Computing topological parameters of biological networks;Assenov;Bioinformatics,2008